Dexlansoprazole MR in Nonerosive Reflux Disease

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02490449

Enrollment

356

Registered

2015-07-03

Start date

2014-12-31

Completion date

Unknown

Last updated

2015-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonerosive Reflux Disease

Brief summary

This study aim is to compare the efficacy of Dexlansoprazole MR intake before and after breakfast in patients with nonerosive reflux disease.

Interventions

DRUGDexlansoprazole MR

Administration of drug after or before diet

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

19 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* NERD confirmed by gastroscopy

Exclusion criteria

* PPI medication within 2 weeks before enrollment

Design outcomes

Primary

Measure	Time frame
Percentage (%) of patients free of reflux symptoms	4 weeks

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026